69 related articles for article (PubMed ID: 21864985)
1. Src inhibitors are promising therapy molecules for human cervical carcinomas.
Al Moustafa AE; Yasmeen A; Alachkar A
Med Hypotheses; 2011 Nov; 77(5):812-4. PubMed ID: 21864985
[TBL] [Abstract][Full Text] [Related]
2. Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses.
Alvarez-Salas LM; Benítez-Hess ML; DiPaolo JA
Antivir Ther; 2003 Aug; 8(4):265-78. PubMed ID: 14518695
[TBL] [Abstract][Full Text] [Related]
3. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.
Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM
Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins.
Yugawa T; Kiyono T
Rev Med Virol; 2009 Mar; 19(2):97-113. PubMed ID: 19156753
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus and cervical cancer.
Crook T; Farthing A
Br J Hosp Med; 1993 Jan 20-Feb 2; 49(2):131-2. PubMed ID: 8382097
[TBL] [Abstract][Full Text] [Related]
6. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297
[TBL] [Abstract][Full Text] [Related]
7. Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA.
DiPaolo JA; Popescu NC; Alvarez L; Woodworth CD
Crit Rev Oncog; 1993; 4(4):337-60. PubMed ID: 8394744
[TBL] [Abstract][Full Text] [Related]
8. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
[TBL] [Abstract][Full Text] [Related]
9. Correlation between the presence of high-risk human papillomaviruses and Id gene expression in Syrian women with cervical cancer.
Darnel AD; Wang D; Ghabreau L; Yasmeen A; Sami S; Akil N; Al Moustafa AE
Clin Microbiol Infect; 2010 Mar; 16(3):262-6. PubMed ID: 19438642
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic, therapeutic and anti-metastatic effects of an HPV-16mE6Delta/mE7/TBhsp70Delta fusion protein vaccine in an animal model.
Qian X; Lu Y; Liu Q; Chen K; Zhao Q; Song J
Immunol Lett; 2006 Feb; 102(2):191-201. PubMed ID: 16242781
[TBL] [Abstract][Full Text] [Related]
11. SRC kinase inhibition: targeting bone metastases and tumor growth in prostate and breast cancer.
Saad F; Lipton A
Cancer Treat Rev; 2010 Apr; 36(2):177-84. PubMed ID: 20015594
[TBL] [Abstract][Full Text] [Related]
12. Involvement of human papillomavirus infections in prostate cancer progression.
Al Moustafa AE
Med Hypotheses; 2008 Aug; 71(2):209-11. PubMed ID: 18468811
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated transfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer.
Hamada K; Shirakawa T; Gotoh A; Roth JA; Follen M
Gynecol Oncol; 2006 Dec; 103(3):820-30. PubMed ID: 16908054
[TBL] [Abstract][Full Text] [Related]
14. Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins.
Narisawa-Saito M; Kiyono T
Cancer Sci; 2007 Oct; 98(10):1505-11. PubMed ID: 17645777
[TBL] [Abstract][Full Text] [Related]
15. Src inhibitors in lung cancer: current status and future directions.
Rothschild SI; Gautschi O; Haura EB; Johnson FM
Clin Lung Cancer; 2010 Jul; 11(4):238-42. PubMed ID: 20630825
[TBL] [Abstract][Full Text] [Related]
16. Src kinase inhibitors: an emerging therapeutic treatment option for prostate cancer.
Edwards J
Expert Opin Investig Drugs; 2010 May; 19(5):605-14. PubMed ID: 20367532
[TBL] [Abstract][Full Text] [Related]
17. Preventative and therapeutic vaccines for cervical cancer.
Roden R; Wu TC
Expert Rev Vaccines; 2003 Aug; 2(4):495-516. PubMed ID: 14711335
[TBL] [Abstract][Full Text] [Related]
18. Protein intrinsic disorder and human papillomaviruses: increased amount of disorder in E6 and E7 oncoproteins from high risk HPVs.
Uversky VN; Roman A; Oldfield CJ; Dunker AK
J Proteome Res; 2006 Aug; 5(8):1829-42. PubMed ID: 16889404
[TBL] [Abstract][Full Text] [Related]
19. Denbinobin suppresses breast cancer metastasis through the inhibition of Src-mediated signaling pathways.
Chen PH; Peng CY; Pai HC; Teng CM; Chen CC; Yang CR
J Nutr Biochem; 2011 Aug; 22(8):732-40. PubMed ID: 21062671
[TBL] [Abstract][Full Text] [Related]
20. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma.
Segawa T; Sasagawa T; Yamazaki H; Sakaike J; Ishikawa H; Inoue M
Cancer; 1999 May; 85(9):2001-10. PubMed ID: 10223242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
